Testing effectiveness (Phase 2)Study completedNCT02841995
What this trial is testing
Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host Disease
Who this might be right for
Graft vs Host Disease
Kadmon, a Sanofi Company 54